According to a recent LinkedIn post from Plenful, the company’s founder and CEO participated in a Learning Lab session at the NHIA 2026 conference to discuss its vision for using AI to transform infusion workflows. The post suggests a focus on reducing manual work and enabling care teams to move faster so they can concentrate on expedited patient care.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The LinkedIn post also notes active engagement with infusion leaders and partners at the event, indicating ongoing business development and networking efforts in the infusion and health system pharmacy segments. For investors, this emphasis on workflow automation and AI-driven efficiency could signal Plenful’s intent to deepen its presence in specialized healthcare operations, potentially expanding its customer base and strengthening its position within pharmacy innovation and workflow automation niches.